
The European Union backs a project to expand tumour genome interpretation for personalised cancer treatment
IDIBGI and ICO Girona participate in a five-year project, funded with 10 million € and involving 17 partner institutions, led by IRB Barcelona.The aim of the consortium is to implement and systematize the interpretation of tumor sequencing in clinical decision-making so that physicians can select …